@article{85c7819e36cf45c7a004b153564b07c5,
title = "Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort",
author = "\{Parker Gregg\}, L. and Richardson, \{Peter A.\} and Julia Akeroyd and Matheny, \{Michael E.\} and Virani, \{Salim S.\} and Navaneethan, \{Sankar D.\}",
note = "Funding Information: funding from Keryx; receiving honoraria from Bayer, Boehringer Ingelheim, REATA, Tricida, and Vifor; and serving as a scientific advisor or member of American Journal of Kidney Diseases, American Journal of Nephrology, CardioRenal Medicine, CJASN, and Current Opinion in Nephrology and Hypertension; and serving as a KDIGO: Guideline writing committee member. P. Richardson reports employment with the US Department of Veterans Affairs. S.S. Virani reports receiving honoraria from the American College of Cardiology as Associate Editor for Innovations, ACC.ORG, and receiving grant support from the Department of Veterans Affairs, World Heart Federation, Tahir, and Jooma Family. The remaining author has nothing to disclose. Funding Information: This work is supported by research funding from the Department of Veterans Affairs Health Services Research \& Development (1I01HX002917-01A1). S.S. Virani is also supported by a grant from the World Heart Federation, NHLBI, and Tahir and Jooma Family. This work was also supported in part by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413), Michael E. DeBakey VA Medical Center, Houston, Texas.",
year = "2022",
month = feb,
doi = "10.2215/CJN.10000721",
language = "English (US)",
volume = "17",
pages = "283--285",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}